The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas

The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas

CTLA-4 blocking therapeutic antibodies are currently under investigation in head and neck squamous cell carcinoma (HNSCC). A better understanding of the epigenetic regulation of the CD28 superfamily members CD28, CTLA-4, and ICOS and their B7 ligands, CD80 and CD86, could support the development of...

Full description

Bibliographic Details
Main Authors:	Luka de Vos, Ingela Grünwald, Emma Grace Bawden, Jörn Dietrich, Kathrin Scheckenbach, Constanze Wiek, Romina Zarbl, Friedrich Bootz, Jennifer Landsberg, Dimo Dietrich
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-11-01
Series:	Epigenetics
Subjects:	cd28 cd80 cd86 ctla4 icos dna methylation immune checkpoint hnscc prognosis tumour microenvironment hpv
Online Access:	http://dx.doi.org/10.1080/15592294.2020.1754675

Similar Items

برهمکنش های مولکولی بین CTLA-4 و CD80/CD86 در تنظیم پاسخ های ایمنی: مقاله مروری
by: زهرا درویش خلیل آبادی, et al.
Published: (2024-01-01)

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
by: Neil Halliday, et al.
Published: (2020-12-01)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
by: Shouheng Lin, et al.
Published: (2021-04-01)

The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis
by: Weixi Liu, et al.
Published: (2021-02-01)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
by: Po-Chun Liu, et al.
Published: (2020-03-01)

Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish
by: Tao-Zhen Lu, et al.
Published: (2022-06-01)

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?
by: Ewelina Grywalska, et al.
Published: (2022-01-01)

CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
by: Blagoje Soskic, et al.
Published: (2021-01-01)

Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells
by: Casimiro Luca Gigliotti, et al.
Published: (2022-09-01)

Differential expression of the costimulatory molecules CD86, CD28, CD152 and PD-1 correlates with the host-parasite outcome in leprosy
by: Maria de Lourdes Palermo, et al.
Published: (2012-12-01)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
by: Guozeng Xu, et al.
Published: (2021-08-01)

Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production
by: Kei Watari, et al.
Published: (2019-10-01)

Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
by: Aina Zhou, et al.
Published: (2023-06-01)

A Distinct Microglial Cell Population Expressing Both CD86 and CD206 Constitutes a Dominant Type and Executes Phagocytosis in Two Mouse Models of Retinal Degeneration
by: Yan Zhang, et al.
Published: (2023-09-01)

CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis
by: Pingping Dong, et al.
Published: (2016-03-01)

CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
by: Dalong Sun, et al.
Published: (2020-01-01)

Two tripartite classification systems of CD86+ and CD206+ macrophages are significantly associated with tumor recurrence in stage II-III colorectal cancer
by: Guozeng Xu, et al.
Published: (2023-06-01)

Costimulatory blockade of the CD28 / CD80-86 / CTLA-4 balance in transplantation: impact on memory T cells?
by: Simon eVille, et al.
Published: (2015-08-01)

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors
by: Hideki Ikeda, MD, et al.
Published: (2023-10-01)

Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
by: David L. Bajor, et al.
Published: (2018-10-01)

EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. A. Zhulai, et al.
Published: (2014-06-01)

Oncolytic vaccinia virus induces a novel phenotype of CD8+ effector T cells characterized by high ICOS expression
by: Midori Yamashita, et al.
Published: (2021-03-01)

The Role of the CD28 Family Receptors in T-Cell Immunomodulation
by: Klaudia Ciesielska-Figlon, et al.
Published: (2024-01-01)

Talaromyces marneffei Can Capture CD86 Proteins of Macrophages in vitro
by: Fang J, et al.
Published: (2022-11-01)

Overexpression of CD86 enhances the ability of THP‐1 macrophages to defend against Talaromyces marneffei
by: Rifeng Chen, et al.
Published: (2022-12-01)

The Effect of Talaromyces marneffei Infection on CD86 Expression in THP-1 Cells
by: Yang D, et al.
Published: (2021-02-01)

CD91 Derived Treg Epitope Modulates Regulatory T Lymphocyte Response, Regulates Expression of Costimulatory Molecules on Antigen-Presenting Cells, and Rescues Pregnancy in Mouse Pregnancy Loss Model
by: Anna Ewa Kedzierska, et al.
Published: (2021-07-01)

Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves’ disease in a Chinese Han population
by: Xiaoming Chen, et al.
Published: (2018-09-01)

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
by: Friederike Hoffmann, et al.
Published: (2023-07-01)

Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia
by: Paulina Mertowska, et al.
Published: (2023-10-01)

Characterization of Co-Stimulatory Ligand CD80/86 and Its Effect as a Molecular Adjuvant on DNA Vaccine Against Vibrio anguillarum in Flounder (Paralichthys olivaceus)
by: Wenjing Liu, et al.
Published: (2022-05-01)

A Model for Apoptotic-Cell-Mediated Adaptive Immune Evasion via CD80–CTLA-4 Signaling
by: Abraam M. Yakoub, et al.
Published: (2019-05-01)

sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection
by: Jil M. Jubel, et al.
Published: (2021-08-01)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
by: Huaide Qiu, et al.
Published: (2021-04-01)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
by: Damian J. Ralser, et al.
Published: (2023-06-01)

The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment
by: A A Popova, et al.
Published: (2013-11-01)

Downregulation of sCD40 and sCTLA4 in Recovered COVID-19 Patients with Comorbidities
by: Gwendolyne Méndez-Frausto, et al.
Published: (2022-09-01)

The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer
by: Linda Hofmann, et al.
Published: (2020-05-01)

Immunohistochemical expression of CD8, CTLA4, and PD-L1 in NSCLC of smokers versus non smokers and its effect on prognosis
by: Rasha. O. Elsaka, et al.
Published: (2022-12-01)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01)